Cargando…

Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial

BACKGROUND: Despite decades of investigation, the balance of clinical risks and benefits of fluid supplementation with starch remain unresolved. Patient-centered outcomes have not been well explored in a “real-world” trial in cardiac surgery. OBJECTIVE: We sought to compare a starch-based fluid stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagpal, A. Dave, Cowan, Andrea, Li, Linna, Nusca, Graeme, Guo, Linrui, Novick, Richard J., Harle, Chris C., House, Andrew A., Fox, Stephanie, Jones, Philip M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388134/
https://www.ncbi.nlm.nih.gov/pubmed/32782813
http://dx.doi.org/10.1177/2054358120940434
_version_ 1783564255672401920
author Nagpal, A. Dave
Cowan, Andrea
Li, Linna
Nusca, Graeme
Guo, Linrui
Novick, Richard J.
Harle, Chris C.
House, Andrew A.
Fox, Stephanie
Jones, Philip M.
author_facet Nagpal, A. Dave
Cowan, Andrea
Li, Linna
Nusca, Graeme
Guo, Linrui
Novick, Richard J.
Harle, Chris C.
House, Andrew A.
Fox, Stephanie
Jones, Philip M.
author_sort Nagpal, A. Dave
collection PubMed
description BACKGROUND: Despite decades of investigation, the balance of clinical risks and benefits of fluid supplementation with starch remain unresolved. Patient-centered outcomes have not been well explored in a “real-world” trial in cardiac surgery. OBJECTIVE: We sought to compare a starch-based fluid strategy with a saline-based fluid strategy in the cardiac surgery patient. DESIGN: A pragmatic blinded randomized controlled trial comparing starch-based with saline-based fluid strategy. SETTING: A large tertiary academic center in London Ontario between September 2009 and February 2011. PARTICIPANTS: Patients undergoing planned, isolated coronary revascularization. MEASUREMENTS: Serum creatinine and patient weight were measured daily postoperatively. METHODS: Patients were randomized to receive 6% hydroxyethyl starch (Voluven) or saline for perioperative fluid requirements. Fluid administration was not protocolized. Co-primary outcomes were incidence of acute kidney injury (AKI) and maximum postoperative weight gain. Secondary outcomes included bleeding, transfusion, inotropic and ventilator support, and fluid utilization. RESULTS: The study was prematurely terminated due to resource limitations. A total of 69 patients (19% female, mean age = 65) were randomized. Using RIFLE criteria for AKI, “risk” occurred in 12 patients in each group (risk ratio [RR] = 1.0; 95% confidence interval [CI] = 0.5-1.9; P = 1.00), whereas “injury” occurred in 7 of 35 (20%) and 3 of 34 (9%) of patients in the starch and saline groups, respectively (RR = 2.3; 95% CI = 0.6-8.1; P = .31). Maximum weight gain, bleeding and blood product usage, and overall fluid requirement were similar between groups. LIMITATIONS: The study had to be prematurely terminated due to resource limitations which led to a small sample size which was not sufficiently powered to detect a difference in the primary outcomes. CONCLUSIONS: This pragmatic double-blinded randomized controlled trial revealed a number of interesting hypothesis-generating trends and confirmed the feasibility of undertaking a logistically complex trial in a pragmatic fashion.
format Online
Article
Text
id pubmed-7388134
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-73881342020-08-10 Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial Nagpal, A. Dave Cowan, Andrea Li, Linna Nusca, Graeme Guo, Linrui Novick, Richard J. Harle, Chris C. House, Andrew A. Fox, Stephanie Jones, Philip M. Can J Kidney Health Dis Original Clinical Research Quantitative BACKGROUND: Despite decades of investigation, the balance of clinical risks and benefits of fluid supplementation with starch remain unresolved. Patient-centered outcomes have not been well explored in a “real-world” trial in cardiac surgery. OBJECTIVE: We sought to compare a starch-based fluid strategy with a saline-based fluid strategy in the cardiac surgery patient. DESIGN: A pragmatic blinded randomized controlled trial comparing starch-based with saline-based fluid strategy. SETTING: A large tertiary academic center in London Ontario between September 2009 and February 2011. PARTICIPANTS: Patients undergoing planned, isolated coronary revascularization. MEASUREMENTS: Serum creatinine and patient weight were measured daily postoperatively. METHODS: Patients were randomized to receive 6% hydroxyethyl starch (Voluven) or saline for perioperative fluid requirements. Fluid administration was not protocolized. Co-primary outcomes were incidence of acute kidney injury (AKI) and maximum postoperative weight gain. Secondary outcomes included bleeding, transfusion, inotropic and ventilator support, and fluid utilization. RESULTS: The study was prematurely terminated due to resource limitations. A total of 69 patients (19% female, mean age = 65) were randomized. Using RIFLE criteria for AKI, “risk” occurred in 12 patients in each group (risk ratio [RR] = 1.0; 95% confidence interval [CI] = 0.5-1.9; P = 1.00), whereas “injury” occurred in 7 of 35 (20%) and 3 of 34 (9%) of patients in the starch and saline groups, respectively (RR = 2.3; 95% CI = 0.6-8.1; P = .31). Maximum weight gain, bleeding and blood product usage, and overall fluid requirement were similar between groups. LIMITATIONS: The study had to be prematurely terminated due to resource limitations which led to a small sample size which was not sufficiently powered to detect a difference in the primary outcomes. CONCLUSIONS: This pragmatic double-blinded randomized controlled trial revealed a number of interesting hypothesis-generating trends and confirmed the feasibility of undertaking a logistically complex trial in a pragmatic fashion. SAGE Publications 2020-07-28 /pmc/articles/PMC7388134/ /pubmed/32782813 http://dx.doi.org/10.1177/2054358120940434 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Clinical Research Quantitative
Nagpal, A. Dave
Cowan, Andrea
Li, Linna
Nusca, Graeme
Guo, Linrui
Novick, Richard J.
Harle, Chris C.
House, Andrew A.
Fox, Stephanie
Jones, Philip M.
Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial
title Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial
title_full Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial
title_fullStr Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial
title_full_unstemmed Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial
title_short Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial
title_sort starch or saline after cardiac surgery: a double-blinded randomized controlled trial
topic Original Clinical Research Quantitative
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388134/
https://www.ncbi.nlm.nih.gov/pubmed/32782813
http://dx.doi.org/10.1177/2054358120940434
work_keys_str_mv AT nagpaladave starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial
AT cowanandrea starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial
AT lilinna starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial
AT nuscagraeme starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial
AT guolinrui starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial
AT novickrichardj starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial
AT harlechrisc starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial
AT houseandrewa starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial
AT foxstephanie starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial
AT jonesphilipm starchorsalineaftercardiacsurgeryadoubleblindedrandomizedcontrolledtrial